6 Cathie Wood Beam Therapeutics Trades
Cathie Wood's position in Beam Therapeutics is currently worth $349 Million. That's 2.09% of their equity portfolio (14th largest holding). The investor owns 11.93% of the outstanding Beam Therapeutics stock. The investor's estimated purchase price is $687 Million, resulting in a loss of 49%.
Avg closing price
Price range
Increased shares by 2.7% (+217 Thousand shares)
Q1 2022
Avg closing price
$65.59
Price range
$53.73
-
$82.16
Increased shares by 16.7% (+1.14 Million shares)
Q4 2021
Avg closing price
$85.62
Price range
$68.02
-
$99.06
Increased shares by 5.9% (+380 Thousand shares)
Q3 2021
Avg closing price
$100.46
Price range
$84.37
-
$133.60
Increased shares by 35.2% (+1.68 Million shares)
Q2 2021
Avg closing price
$79.68
Price range
$64.12
-
$128.71
Increased shares by 322.3% (+3.65 Million shares)
Q1 2021
Avg closing price
$95.13
Price range
$71.28
-
$120.75
New holding (+1.13 Million shares)
Q4 2020
Avg closing price
$49.18
Price range
$22.24
-
$95.63
